Content Block Tag: NRG-BN009: Recurrent Brain Cancer After SRS

‘Text/HTML’ of page ‘NRG-BN009: Recurrent Brain Cancer After SRS’

Am I eligible for this study? If you are over the age of 18, if you received stereotactic radiosurgery to treat cancer that spread to your brain and now the cancer has returned in other areas of the brain, and if your BMV is four or higher, you may be able to participate. Your healthcare […]

Read More

‘Text/HTML’ of page ‘NRG-BN009: Recurrent Brain Cancer After SRS’

  About This Study NRG-BN009 is a clinical study for people with cancer that has spread to the brain and come back in other areas of the brain after earlier stereotactic radiosurgery (SRS). Brain Metastasis Velocity (BMV) is a measure of how fast the cancer is spreading in your brain. If you have a BMV of […]

Read More

‘Text/HTML’ of page ‘NRG-BN009: Recurrent Brain Cancer After SRS’

Clinical Studies FAQ

Read More

‘Text/HTML’ of page ‘NRG-BN009: Recurrent Brain Cancer After SRS’

The NRG-BN009 Study FAQ

Read More